Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers
about
Eicosanoids and Keratinocytes in Wound HealingCUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.
P2860
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers
@en
type
label
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers
@en
prefLabel
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers
@en
P2093
P2860
P1476
Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers
@en
P2093
Allison Knutson
Andrew J Dannenberg
Anna J Duffield-Lillico
Arash Mohebati
Esther G Akpa
Jay O Boyle
Lawrence J Marnett
Philip J Kingsley
Powel H Brown
P2860
P304
P356
10.1158/1940-6207.CAPR-13-0083
P577
2013-05-16T00:00:00Z